Thermon appoints Dr. Angela Strzelecki to board of directors

Thermon Group Holdings, Inc.

Appointed Dr. Angela Strzelecki as director effective September 6, 2022; board size increased from 7 to 8.
She currently serves as President of Pharmaceutical Solutions at IFF (NYSE:IFF) and previously held global roles at DuPont.
She will serve on the Finance, Human Capital Management and Compensation, and Nominating and Corporate Governance Committees.
Received a pro-rated annual grant of ~$6,454 in common stock under the 2020 Long-Term Incentive Plan.
Board determined she is independent under NYSE standards.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Dr. Angela Strzelecki

director

THR · Thermon Group Holdings, Inc.

Effective: 2022-09-06
Filed: September 6, 2022, 7:59 PM ET

appointed Dr. Angela Strzelecki as a director of the Company, effective as of September 6, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. Angela Strzelecki was appointed as director at Thermon Group Holdings, Inc..

Action: appointed
Role: director

Exact text from the filing

appointed Dr. Angela Strzelecki as a director of the Company, effective as of September 6, 2022.

View on SEC.gov

Thermon Group Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001489096-22-000127

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.